Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Supportive Oncology|April 13, 2010
Pegfilgrastim dosing on same day as myelosuppressive chemotherapy for ovarian or primary peritoneal cancerSamer I Schuman, Nicholas Lambrou, Katie Robson, et al.
Gynecologic Oncology|November 24, 2018
Identifying the need to refine the potential patient risk factors for niraparib-induced thrombocytopeniaJudith A Smith, Tran Le, Grace A Martin, et al.
Cancer Research|July 4, 2003
Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cellsLyuba Levine, Joseph A Lucci, Barbara Pazdrak, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Frozen section underestimates the need for surgical staging in endometrial cancer patientsAndrea Papadia, Guglielmo Azioni, Bruno Brusacà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group studyRachelle Lanciano, Alison Calkins, Brian N Bundy, et al.
Gynecologic Oncology|March 3, 2009
A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancerEdwin A Alvarez, Aaron H Wolfson, J Matt Pearson, et al.
Gynecologic Oncology|April 9, 2011
A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometriumDené C Wrenn, Kunal Saigal, Joseph A Lucci, et al.
Frontiers in Oncology|July 11, 2022
AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus InfectionsJudith A Smith, Anjali A Gaikwad, Lata Mathew, et al.
Gynecologic Oncology|November 27, 2007
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancerGillian Thomas, Shamshad Ali, Frank J P Hoebers, et al.
Frontiers in Oncology|April 6, 2019
From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus InfectionsJudith A Smith, Lata Mathew, Anjali Gaikwad, et al.
Pageof 4